Article Link: FDA Approves Vitrakvi (larotrectinib) for TRK Fusion Cancers November 26, 2018 — The U.S. Food and Drug Administratio...
FDA Approves The ACTpen for Actemra, A Single-Dose, Prefilled Autoinjector
Article Link: FDA Approves The ACTpen for Actemra, A Single-Dose, Prefilled Autoinjector South San Francisco, CA — November 26, 201...
FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia
Article Link: FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia November 21, 2018 — The U.S. Food and Drug...
Genentech Announces FDA Grants Venclexta Accelerated Approval for People With Newly-Diagnosed Acute Myeloid Leukemia or Those Who Are Ineligible For Intensive Induction Chemotherapy
Article Link: Genentech Announces FDA Grants Venclexta Accelerated Approval for People With Newly-Diagnosed Acute Myeloid Leukemia or Those Who Are In...
FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis
Article Link: FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis November 20, 2018 — The U.S. F...
FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
Article Link: FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea November 16, 2018 — The U.S. Food and Drug Administrati...
FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
Article Link: FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic La...
FDA Approves Promacta (eltrombopag) for First-Line Severe Aplastic Anemia
Article Link: FDA Approves Promacta (eltrombopag) for First-Line Severe Aplastic Anemia Basel, November 16, 2018 – Novartis announc...
FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)
Article Link: FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) November 09, 2018 — Today, the U....
FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
Article Link: FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated...
